Pular para o conteúdo

Zealand, Roche Start Petrelintide Phase 3 as 100% Pharma Tariffs Begin — September 29, 2026

29 de setembro de 2026 · 9 min

Notas do episódio

Zealand Pharma and Roche have launched a roughly 7,000-person Phase 3 program for once-weekly petrelintide in obesity. Meanwhile, a baseline 100 percent Section 232 tariff on imported patented medicines and ingredients takes effect and EASD convenes in Milan.

In this episode
  1. Global Registrational Phase 3 ZUPREME Program Evaluating Petrelintide in Overweight or Obesity Initiated – Zealand Pharma - Medical Update Online — Medical Update Online

    Global Registrational Phase 3 ZUPREME Program Evaluating Petrelintide in Overweight or Obesity Initiated – Zealand Pharma - Medical Update Online # Global Registrational Phase 3 ZUPREME Program Evaluating Petrelintide in Overweight or Obesity Initiated – Zealand Pharma Written by Charlie King | 27 Sep 2026 | Diabetes & Endocrinology Zealand Pharma A/S announces the initiation of the global…

  2. Navigating Pharma’s Forced Supply Chain Revolution - Chemistry Today — Chemistry Today

    Navigating Pharma’s Forced Supply Chain Revolution - Chemistry Today # Navigating Pharma’s Forced Supply Chain Revolution by [email protected] 28 September 2026 M. Klote 28 September 2026 Molly Klote, MD President and CEO, Klote Medical Research Advisors, LLC, Washington, DC, United States Former Director, Office for Human Research Protections, US Department of Health and Human…

  3. EASD 2026 to Feature New Diabetes Approaches in T1DM, T2DM, obesity - Dagensdiabetes — Dagens Diabetes

    EASD 2026 to Feature New Diabetes Approaches in T1DM, T2DM, obesity - Dagensdiabetes Senaste Nr DiabetologNytt i PDF ## EASD 2026 to Feature New Diabetes Approaches in T1DM, T2DM, obesity Key Points • This year’s European Association for the Study of Diabetes (EASD) 2026 Annual Meeting in Milan, Italy, (from September 28 to October 2) will feature new data on first-line treatment approaches…

  4. Republicans and Democrats Find a Unifying Target: Pharmacy Benefit Managers — KFF Health News

    Amye Joseph says America’s political polarization has made it an “interesting time” in her Tennessee household. She and her husband, Charlie, have been married 35 years. She’s a Republican. He’s a Democrat. But their shared disenchantment with profit-driven healthcare has provided a unifying target: pharmacy benefit managers, known as PBMs. The Josephs’ frustration is focused on CVS Health. The…

  5. Oral solid dose at a turning point: Scaling for the next generation of therapies - Pharmaceutical Technology — Pharmaceutical Technology

    Oral solid dose at a turning point: Scaling for the next generation of therapies - Pharmaceutical Technology # Oral solid dose at a turning point: Scaling for the next generation of therapies From patient-centric designs and sustainable changes to component shortages, anti-counterfeiting, and low-volume production, sponsors of oral solid dose pharmaceuticals and their CDMOs are navigating a…

Daily TopFive for GLP-1 Daily. Links above go to the original articles. Follow and rate GLP-1 Daily on Apple Podcasts. Feedback? Email [email protected].

Todos os episódios de GLP-1 Daily: Ozempic & Wegovy News

Configurações

Exibição

Idioma

Define quais estações você vê primeiro na página inicial.

Histórico

As rádios e episódios ouvidos recentemente e suas últimas buscas ficam só neste navegador.

Avisos

Um aviso rápido quando um podcast que você segue tem um episódio novo. Desative podcasts individuais pelo sino na página deles.

Conta

Salve favoritos – no app e no site.

Atalhos de teclado

/
Abrir busca
Espaço
Reproduzir ou pausar
← →
No player: voltar 15 s, avançar 30 s (episódios) · na fileira: próximo bloco
↑ ↓
Na fileira: alvo dentro do bloco
Home / End
Na fileira: primeiro ou último bloco
Esc
Fechar janela ou menu
?
Esta visão geral
Tocando agora

Ir para a estação

A seguir

    Adicione episódios com “A seguir” – eles tocam depois do episódio atual.